Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled Trial-Reference-Cited by-同舟云学术

Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled Trial

Published:2024-05-01 Issue:5 Volume:181 Page:403-411
ISSN:0002-953X
Container-title:American Journal of Psychiatry
language:en
Short-container-title:AJP

Author:

Morley Kirsten C.¹,Kranzler Henry R.¹,Luquin Natasha¹,Jamshidi Nazila¹,Adams Claire¹,Montebello Mark¹,Tremonti Chris¹,Dali Gezelle¹,Logge Warren¹,Baillie Andrew¹,Teesson Maree¹,Trent Ronald¹,Haber Paul S.¹

Affiliation:

1. Specialty of Addiction Medicine, Sydney Medical School (Morley, Adams, Montebello, Tremonti, Dali, Logge, Haber), School of Health Sciences (Baillie), and Matilda Centre for Mental Health and Substance Use (Teesson), Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Edith Collins Centre for Translational Research in Alcohol, Drugs, and Toxicology (Morley, Jamshidi, Logge, Haber) and Department of Medical Genomics (Luquin, Trent), Royal Prince Alfred Hospital, Camperdown, Australia;...

Publisher

American Psychiatric Association Publishing

Reference27 articles.

1. New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies

2. Commentary on Donoghue: Low prescribing rates of pharmacotherapy for alcohol use disorder limit potential public health impact

3. Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings

4. National trends in alcohol pharmacotherapy: Findings from an Australian claims database

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Substance Use Disorders: Confronting Addiction From Prevention to Recovery;American Journal of Psychiatry;2024-05-01